scorecardresearch
Thursday, July 24, 2025
TopicCovishield

Topic: Covishield

India to have 18-22 crore vaccine doses by September, ZyCoV D could take longer to hit market

The increase in vaccine procurement is good news in terms of daily vaccination numbers, but govt's stated target of 1 crore daily vaccinations still some time away.

India’s drug regulator approves study on mixing of Covaxin, Covishield vaccine doses

The Central Drugs Standard Control Organisation on 29 July had recommended granting permission to the study that will be conducted by the Christian Medical College in Vellore.

Covishield shot followed by Covaxin safe, provides better immunogenicity, finds ICMR study

Researchers studied 18 cases where recipients were administered a first dose of Covishield, and “inadvertently” received Covaxin as the second dose.

Adar Poonawalla sets aside fund of Rs 10 cr to support Indian students travelling abroad

Poonawalla said a few countries are yet to approve Covishield as an acceptable vaccine for travel so he will be supporting students abroad who may have to incur costs on quarantine.

Covishield production projected to reach 120 mn doses/month, Covaxin to 58 mn doses: Mandaviya

Health minister Mansukh Mandaviya while responding to a question on the current capacity to manufacture Covid vaccines said it is projected to go forward from August to December 2021.

SII chairman Cyrus Poonawalla to receive Lokmanya Tilak award for manufacturing Covishield

In an announcement Saturday, Deepak Tilak, president of Lokmanya Tilak Trust said Poonawalla will be felicitated for his work during the Covid-19 pandemic.

Animal trials suggest intranasal version of AstraZeneca shot may prevent Covid transmission

Currently tested on animals, researchers now intend to test the effectiveness of intranasal vaccines, in both preventing infection and lowering viral shedding in humans.

Covishield offers 93% protection against Covid, 98% mortality reduction, study finds

The findings of the study conducted by Armed Forces Medical College during Covid 2nd wave were presented by NITI Aayog Member (Health) Dr V K Paul Tuesday.

15 crore vaccine doses expected in August delays plan of 1 crore daily shots

Talks are still on with Moderna, Sputnik yet to be procured for the national Covid vaccination programme, which means Covishield and Covaxin will remain the mainstay.

Covishield protected 97.4% of staff from infection in a Delhi hospital, IJMR study finds

Study period was from 16 January to 24 April 2021, among 3,235 healthcare workers of Delhi's Indraprastha Apollo Hospital. Only 85 reported symptomatic infection after vaccination.

On Camera

Defence, tech, education—Modi’s visit will boost India-UK ties

Given the immediate challenges on India’s borders, cooperation in the defence sector with partners such as the UK has achieved greater importance.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Indian firm sets up titanium, superalloy plants to meet global need. Safran, Dassault, BAE line up

PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.